Co-Diagnostics Inc. (CODX)
NASDAQ: CODX
· Real-Time Price · USD
0.30
-0.00 (-0.03%)
At close: Jun 09, 2025, 3:59 PM
-0.03% (1D)
| Bid | 0.26 |
| Market Cap | 10.11M |
| Revenue (ttm) | 1M |
| Net Income (ttm) | -35.86M |
| EPS (ttm) | -1.17 |
| PE Ratio (ttm) | -0.26 |
| Forward PE | -0.73 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 0.32 |
| Volume | 435,320 |
| Avg. Volume (20D) | 357,788 |
| Open | 0.28 |
| Previous Close | 0.30 |
| Day's Range | 0.28 - 0.31 |
| 52-Week Range | 0.23 - 2.23 |
| Beta | 0.58 |
| Ex-Dividend Date | n/a |
About CODX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CODX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CODX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCo-Diagnostics Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 day ago
+80.76%
Co-Diagnostics shares are trading higher after the...
Unlock content with
Pro Subscription
1 month ago
+10.85%
Co-Diagnostics shares are trading higher after the company reported better-than-expected Q2 financial results.
1 month ago · seekingalpha.com
Co-Diagnostics, Inc. (CODX) Q2 2025 Earnings Conference Call TranscriptCo-Diagnostics, Inc. (NASDAQ:CODX ) Q2 2025 Earnings Conference August 14, 2025 4:30 PM ET Company Participants Andrew Benson - Head of Investor Relations Brian L. Brown - CFO & Company Secretary Dwig...
